RARX - Ra Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-64,943-54,439-28,864-13,943
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,5971,5241,274897
Adjustments To Net Income7,6715,5812,070694
Changes In Accounts Receivables----
Changes In Liabilities1,1262,0122,156219
Changes In Inventories----
Changes In Other Operating Activities-397-1,4571,52166
Total Cash Flow From Operating Activities-54,946-46,779-21,843-12,017
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-1,034-1,412-5,105-331
Investments----
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-1,034-1,412-5,096-330
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings---5,000
Other Cash Flows from Financing Activities-377494-2,132-198
Total Cash Flows From Financing Activities195,421760125,23629,028
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents139,441-47,43198,29716,681